# X4 Pharmaceuticals, Inc: Form SCHEDULE 13D, filed Aug 18, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: SCHEDULE 13D
- Filed: 2025-08-18
- Accepted by EDGAR: Aug 18, 2025, 16:26 ET
- Period: not reported
- Accession: 0001104659-25-079821
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000110465925079821/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000110465925079821/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000110465925079821/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-079821. Last ingested by Listed: Nov 4, 2026, 16:53 ET. No prices; not investment advice.